Vimarsana
Biggest News Aggregation in the World

Page 21 - Masi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Masi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Masi Today - Breaking & Trending Today

Masimo Plans to Lower 2023 Rev Guidance, 2Q Expected to Underperform - Vimarsana News

Masimo Plans to Lower 2023 Rev Guidance, 2Q Expected to Underperform

By Denny Jacob Masimo Corp. said Monday it plans to lower its full-year revenue guidance as revenue for the second quarter is expected to come in below its...

Stocks to Watch: FB Financial, Masimo, Acumen Pharmaceuticals, CEL-SCI, Karyopharm Therapeutics - Vimarsana News

Stocks to Watch: FB Financial, Masimo, Acumen Pharmaceuticals, CEL-SCI, Karyopharm Therapeutics

By Sabela Ojea FB Financial posted a surge in profit amid a stronger capital base in the second quarter of the year. Shares of the parent company of...

Masimo stock gets hit after executives cite weaker sales, fewer hospital patients - Vimarsana News

Masimo stock gets hit after executives cite weaker sales, fewer hospital patients

Shares of Masimo Corp. on Monday tumbled 25% after hours after the hospital-equipment maker forecast second-quarter sales that were far below estimates and...

Brokerages Set Masimo Co. (NASDAQ:MASI) Target Price at $188.88 - Vimarsana News

Brokerages Set Masimo Co. (NASDAQ:MASI) Target Price at $188.88

Masimo Co. (NASDAQ:MASI – Free Report) has been given an average recommendation of “Moderate Buy” by the eight research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price objective […]

Masimo and Vera Therapeutics Stock See Action From Activist Investors - Vimarsana News

Masimo and Vera Therapeutics Stock See Action From Activist Investors

Politan Capital won two seats on the board of monitoring-tech firm Masimo. Carlyle Group cut its stake in pharmaceuticals firm Vera.